Skip to main content

PAVmed Inc (PAVM) Stock

PAVmed Inc Stock Details, Movements and Public Alerts

Stock Details

PAVmed Inc (PAVM), a prominent company in the healthcare sector within the medical devices industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $0.51. Over the past 52 weeks, it has ranged between $0.30 and $1.29. This places the current price at 39.4% of its 52-week high and 67.8% above its 52-week low. Recent trading volume was recorded at 31. The 14-day Relative Strength Index (RSI) stands at 61.13, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $0.46 by 10.87%. Similarly, it is below its 200-day moving average of $0.61 by 16.39%. The MACD histogram is 0.01, indicating bullish momentum0. There are currently 3 active alerts set for PAVM by users.

Market Cap

$9.86M

52-Week High

$1.29

-60.56% from high

52-Week Low

$0.30

+67.76% from low

Avg Daily Volume

224,643

20-day average

100-day avg: 213,464

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

0.10

Below market average

PEG Ratio

0.00

Potentially undervalued

Price to Book

0.74

EV/EBITDA

0.62

EPS (TTM)

$4.41

Price to Sales

9.67

Beta

1.07

Similar volatility to market

How is PAVM valued relative to its earnings and growth?
PAVmed Inc trades at a P/E ratio of 0.10, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong.0
What is PAVM's risk profile compared to the market?
With a beta of 1.07, PAVmed Inc is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 0.74 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

7145.00%

Operating Margin

-78583.00%

Return on Equity

10.70%

Return on Assets

-40.40%

Revenue Growth (YoY)

-99.40%

Earnings Growth (YoY)

0.00%

How profitable and efficient is PAVM's business model?
PAVmed Inc achieves a profit margin of 7145.00%, meaning it retains $7145.00 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of -78583.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 10.70% and ROA at -40.40%, the company achieves moderate returns on invested capital.
What are PAVM's recent growth trends?
PAVmed Inc's revenue declined by 99.40% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against MEDICAL DEVICES industry averages for proper context.

Company Size & Market

Shares Outstanding

21.93M

Book Value/Share

$0.64

Asset Type

Common Stock

What is PAVM's market capitalization and position?
PAVmed Inc has a market capitalization of $9.86M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 21.93M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL DEVICES industry, it competes with other firms in this sector.
How does PAVM's price compare to its book value?
PAVmed Inc's book value per share is $0.64, while the current stock price is $0.51, resulting in a price-to-book (P/B) ratio of 0.79. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$11.00

2056.86% upside potential

Analyst Recommendations

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for PAVM?
2 analysts cover PAVM with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $11.00 implies 2056.9% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on PAVM?
Current analyst recommendations:1 Strong Buy, 1 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 8, 2025, 05:44 AM

Earnings Dates

Recent Earnings History

DateQuarterEstimated EPSActual EPSSurprise
Aug 14, 2025Q2$-0.25$-0.74-196.0%
May 15, 2025Q1$-0.29$-0.07+75.9%
Mar 25, 2025Q4$-0.40$-0.19+52.5%
Nov 13, 2024Q3$1.97$-0.54-127.4%
Aug 13, 2024Q2$-1.45$-1.19+17.9%
May 13, 2024Q1$-1.67$-2.62-56.9%
Mar 26, 2024Q4$-1.89$-1.81+4.2%
Nov 14, 2023Q3$-0.14$-0.16-14.3%

Technical Indicators

RSI (14-day)

61.13

Neutral

50-Day Moving Average

$0.46

10.87% above MA-50

200-Day Moving Average

$0.61

-16.39% below MA-200

MACD Line

N/A

MACD Signal

-0.01

MACD Histogram

0.01

Bullish

What does PAVM's RSI value tell investors?
The RSI (Relative Strength Index) for PAVM is currently 61.13, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret PAVM's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.00 above the signal line at -0.01, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.46) is below the 200-day MA ($0.61), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: Oct 8, 2025, 05:44 AM

Active Alerts

Alert Condition
RSI Threshold Cross
Threshold
55
Created
Oct 8, 2025, 05:45 AM
Alert Condition
Volume change
Threshold
300%
Created
Oct 8, 2025, 05:45 AM
Alert Condition
Price falls below
Threshold
$0.45
Created
Oct 8, 2025, 05:45 AM

Stay Ahead of the Market with PAVmed Inc Alerts

Set up price alerts for PAVmed Inc and get notified instantly when the price hits your target. Never miss an important price movement again.